Drs. Ibach and Terveen will discuss postoperative pain after ophthalmic surgeries, including the severity and incidence of it, the challenges faced when managing it, and current treatments available.
This activity is supported by an unrestricted medical educational grant from Ocular Therapeutix.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education, LLC is a COPE-accredited administrator.
This activity, COPE Activity Number 124671, is accredited by COPE for continuing education for optometrists. This course is approved for 1 hours CE.
Course #: 80566-TD
Activity #: 124671
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Mitch Ibach, OD, FAAO
Cataract, Cornea, Refractive, and Glaucoma Surgery Specialist
Vance Thompson Vision
Sioux Falls, SD
Daniel C. Terveen, MD
Specialist in Glaucoma, Cornea, External Disease and Refractive Surgery
Vance Thompson Vision
Sioux Falls, SD
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Mitch Ibach, OD, FAAO, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Avellino, Bausch + Lomb, Dompé, Gauch Health, Glaukos, Heru, Kala Pharmaceuticals, Ocular Therapeutix, Oyster Point, and Sight Sciences. Grant/Research Support: Ocular Therapeutix. Speakers’ Bureau: Aerie Pharmaceuticals, Dompé, Glaukos, Heru, Ocular Therapeutix, Oyster Point, Sight Sciences, and Sun Pharmaceutical Industries. Stock/Shareholder: Equinox.
Daniel C. Terveen, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Trefoil. Grant/Research Support: Sight Sciences, Glaukos, and Alcon. Shareholder: Equinox and Expert Opinion.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Ocular Therapeutix.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Yewlin E. Chee, MD
Camila Ventura MD, PhD
Edward Wood, MD
Tony Capone Jr, MD
Katherine E. Talcott, MD
Nassim Abreu, MD
